BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues

BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues

Submitted by admin on February 13, 2024 - 11:31am
Source: 
Fierce Biotech
News Tags: 
Bristol Myers Squibb
Roivant
VantAI
artificial intelligence
molecular glue
Headline: 
BMS signs $674M biobucks pact with Roivant's VantAI for molecular glues
snippet: 

Bristol Myers Squibb is offering Roivant's VantAI up to $674 million biobucks in a new partnership aimed at designing molecular glues as small-molecule therapeutics.

Do Not Allow Advertisers to Use My Personal information